8.46  -0.41 (-4.62%)		04-24 16:00
Open: 9.04 High: 9.04 Volume: 827,031		Pre. Close: 8.87 Low: 8.42 Market Cap: 596(M)

Short term
Mid term
Targets	6-month :	12.5	1-year :	14.27
Resists	First :	10.7	Second :	12.22
Pivot price	9.75
Supports	First :	8.26	Second :	6.87
MAs	MA(5) :	8.72	MA(20) :	9.81
	MA(100) :	5.98	MA(250) :	4.52
MACD	MACD :	0	Signal :	0.3
%K %D	K(14,3) :	10.3	D(3) :	9.7
RSI	RSI(14): 43.2
52-week	High :	12.22	Low :	2.41

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ MNMD ] has closed above bottom band by 12.4%. Bollinger Bands are 61.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	9.05 - 9.1	9.1 - 9.15
Low:	8.31 - 8.36	8.36 - 8.41
Close:	8.38 - 8.47	8.47 - 8.55

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder, as well as for the treatment of chronic pain; and MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. It also develops MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company is headquartered in Vancouver, Canada.

Thu, 25 Apr 2024
MindMed to Present at Upcoming May Medical Conferences - Business Wire

Tue, 23 Apr 2024
Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Up 6.8% - MarketBeat

Tue, 23 Apr 2024
Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Down 3.5% - MarketBeat

Sun, 14 Apr 2024
Why Earnings Season Could Be Great for Mind Medicine (MNMD) - Yahoo Movies UK

Mon, 08 Apr 2024
MindMed (MNMD) Stock Rises 154% in 3 Months: Here's Why - Yahoo Finance

Tue, 19 Mar 2024
Mind Medicine (MindMed) Inc (MNMD) Up 4.94% in Premarket Trading - InvestorsObserver

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	71 (M)
Shares Float	33 (M)
Held by Insiders	2.4 (%)
Held by Institutions	25.3 (%)
Shares Short	7,230 (K)
Shares Short P.Month	4,220 (K)

EPS	-2.45
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	1.89
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-39.9 %
Return on Equity (ttm)	-83.6 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	-64 (M)
Levered Free Cash Flow	-26 (M)

PE Ratio	-3.47
PEG Ratio	0
Price to Book value	4.45
Price to Sales	0
Price to Cash Flow	-9.27

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.